• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 Fc 构建更好的抗体:利用抗体 Fc 效应功能获得抗病毒保护的进展和挑战。

Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection.

机构信息

Paul G. Allen School of Global Health, College of Veterinary Medicine, Washington State University, Pullman, WA, USA.

出版信息

Hum Vaccin Immunother. 2021 Nov 2;17(11):4328-4344. doi: 10.1080/21645515.2021.1976580. Epub 2021 Oct 6.

DOI:10.1080/21645515.2021.1976580
PMID:34613865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8827636/
Abstract

Antibodies can provide antiviral protection through neutralization and recruitment of innate effector functions through the Fc domain. While neutralization has long been appreciated for its role in antibody-mediated protection, a growing body of work indicates that the antibody Fc domain also significantly contributes to antiviral protection. Recruitment of innate immune cells such as natural killer cells, neutrophils, monocytes, macrophages, dendritic cells and the complement system by antibodies can lead to direct restriction of viral infection as well as promoting long-term antiviral immunity. Monoclonal antibody therapeutics against viruses are increasingly incorporating Fc-enhancing features to take advantage of the Fc domain, uncovering a surprising breadth of mechanisms through which antibodies can control viral infection. Here, we review the recent advances in our understanding of antibody-mediated innate immune effector functions in protection from viral infection and review the current approaches and challenges to effectively leverage innate immune cells via antibodies.

摘要

抗体可以通过中和作用和 Fc 结构域募集先天效应功能来提供抗病毒保护。虽然中和作用长期以来一直因其在抗体介导的保护中的作用而受到重视,但越来越多的研究表明,抗体的 Fc 结构域也显著有助于抗病毒保护。抗体可以招募自然杀伤细胞、中性粒细胞、单核细胞、巨噬细胞、树突状细胞和补体系统等先天免疫细胞,从而直接限制病毒感染,并促进长期抗病毒免疫。针对病毒的单克隆抗体治疗越来越多地采用 Fc 增强特性来利用 Fc 结构域,揭示了抗体控制病毒感染的惊人广泛的机制。在这里,我们综述了我们对抗体介导的先天免疫效应功能在抗病毒感染中的保护作用的最新理解,并综述了通过抗体有效利用先天免疫细胞的当前方法和挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ce5/8827636/f71ef2fbb4b6/KHVI_A_1976580_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ce5/8827636/f5e3554bba72/KHVI_A_1976580_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ce5/8827636/f71ef2fbb4b6/KHVI_A_1976580_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ce5/8827636/f5e3554bba72/KHVI_A_1976580_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ce5/8827636/f71ef2fbb4b6/KHVI_A_1976580_F0002_C.jpg

相似文献

1
Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection.通过 Fc 构建更好的抗体:利用抗体 Fc 效应功能获得抗病毒保护的进展和挑战。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4328-4344. doi: 10.1080/21645515.2021.1976580. Epub 2021 Oct 6.
2
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus.Fc 功能在治疗性单克隆抗体预防埃博拉病毒中的作用。
Cell Host Microbe. 2018 Aug 8;24(2):221-233.e5. doi: 10.1016/j.chom.2018.07.009.
3
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus.一种 Fc 工程改造方法,用于鉴定针对埃博拉病毒的体液免疫功能相关因素。
Immunity. 2021 Apr 13;54(4):815-828.e5. doi: 10.1016/j.immuni.2021.03.009.
4
Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects.疫苗抗体:Fc 抗体工程改造以提高抗病毒抗体反应并诱导类疫苗效应。
Hum Vaccin Immunother. 2021 Dec 2;17(12):5532-5545. doi: 10.1080/21645515.2021.1985891. Epub 2021 Nov 29.
5
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection.超越中和作用:Fc 依赖性抗体效应功能在 SARS-CoV-2 感染中的作用。
Nat Rev Immunol. 2023 Jun;23(6):381-396. doi: 10.1038/s41577-022-00813-1. Epub 2022 Dec 19.
6
Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine.额外的中和 FcR 介导的抗体功能用于通用流感疫苗。
Front Immunol. 2019 Mar 18;10:440. doi: 10.3389/fimmu.2019.00440. eCollection 2019.
7
Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.广泛中和的血凝素茎特异性抗体以Fc依赖的方式诱导中性粒细胞对免疫复合物进行有效的吞噬作用。
mBio. 2016 Oct 4;7(5):e01624-16. doi: 10.1128/mBio.01624-16.
8
Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections.抗体基于Fc-Fcγ 受体相互作用的新兴病毒感染的保护作用要求。
Viruses. 2021 May 31;13(6):1037. doi: 10.3390/v13061037.
9
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.COVID-19 严重程度与抗体 Fc 介导的固有免疫功能的差异有关。
mBio. 2021 Apr 20;12(2):e00281-21. doi: 10.1128/mBio.00281-21.
10
The protective potential of Fc-mediated antibody functions against influenza virus and other viral pathogens.Fc 介导的抗体功能对流感病毒和其他病毒病原体的保护潜力。
Immunol Cell Biol. 2020 Apr;98(4):253-263. doi: 10.1111/imcb.12312. Epub 2020 Feb 3.

引用本文的文献

1
Analysis of Fc-dependent effector functions of anti-malaria circumsporozoite protein antibodies.抗疟疾环子孢子蛋白抗体的Fc依赖性效应功能分析
Microbiol Spectr. 2025 Jul 23:e0086325. doi: 10.1128/spectrum.00863-25.
2
Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials.一种具有复制能力的基于水疱性口炎病毒的拉沙病毒候选疫苗的临床前开发已推进到人体临床试验阶段。
EBioMedicine. 2025 Apr;114:105647. doi: 10.1016/j.ebiom.2025.105647. Epub 2025 Mar 28.
3
Zika virus vaccines and monoclonal antibodies: a priority agenda for research and development.

本文引用的文献

1
Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.通过 FcγRIIA 和 C5a-C5aR 途径的信号传导介导 COVID-19 中的血小板过度激活。
Front Immunol. 2022 Mar 3;13:834988. doi: 10.3389/fimmu.2022.834988. eCollection 2022.
2
Antibody fucosylation predicts disease severity in secondary dengue infection.抗体岩藻糖基化可预测二次登革热感染的疾病严重程度。
Science. 2021 Jun 4;372(6546):1102-1105. doi: 10.1126/science.abc7303.
3
Decay of Fc-dependent antibody functions after mild to moderate COVID-19.
寨卡病毒疫苗和单克隆抗体:研发的优先议程
Lancet Infect Dis. 2025 Jul;25(7):e402-e415. doi: 10.1016/S1473-3099(24)00750-3. Epub 2025 Feb 27.
4
With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process.能力越大,责任越大:在抗体研发过程早期广泛衡量Fc介导的效应子功能的重要性。
MAbs. 2025 Dec;17(1):2453515. doi: 10.1080/19420862.2025.2453515. Epub 2025 Jan 16.
5
Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.使用联合佐剂进行异源肌内mRNA初免/鼻内蛋白加强免疫后增强的黏膜严重急性呼吸综合征冠状病毒2免疫力
Mol Ther. 2024 Dec 4;32(12):4448-4466. doi: 10.1016/j.ymthe.2024.10.016. Epub 2024 Oct 28.
6
Defining correlates of protection for mammalian livestock vaccines against high-priority viral diseases.定义针对高优先级病毒病的哺乳动物疫苗的保护相关因素。
Front Immunol. 2024 Jul 19;15:1397780. doi: 10.3389/fimmu.2024.1397780. eCollection 2024.
7
Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection.超越广谱中和抗体:非中和抗体在病毒感染治疗应用中的用途、风险与机遇
Antibodies (Basel). 2024 Apr 3;13(2):28. doi: 10.3390/antib13020028.
8
NIAID/SMB Workshop on Multiscale Modeling of Infectious and Immune-Mediated Diseases.NIAID/SMB 传染病与免疫介导疾病多尺度建模研讨会。
Bull Math Biol. 2024 Mar 21;86(5):44. doi: 10.1007/s11538-024-01276-2.
9
Passive antibody transfer from pregnant women to their fetus are maximized after SARS-CoV-2 vaccination irrespective of prior infection.无论先前是否感染过新冠病毒,孕妇在接种新冠病毒疫苗后,其向胎儿的被动抗体转移都能达到最大化。
J Allergy Clin Immunol Glob. 2023 Nov 22;3(1):100189. doi: 10.1016/j.jacig.2023.100189. eCollection 2024 Feb.
10
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody.用去岩藻糖基化单克隆抗体对非人类灵长类动物进行雾化马尔堡病毒的长期预防。
J Infect Dis. 2023 Nov 13;228(Suppl 7):S701-S711. doi: 10.1093/infdis/jiad278.
轻度至中度 COVID-19 后 Fc 依赖性抗体功能的衰减。
Cell Rep Med. 2021 Jun 15;2(6):100296. doi: 10.1016/j.xcrm.2021.100296. Epub 2021 May 9.
4
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma.恢复期血浆中 SARS-CoV-2 多功能抗体的标志物。
mBio. 2021 Apr 20;12(2):e00765-21. doi: 10.1128/mBio.00765-21.
5
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus.一种 Fc 工程改造方法,用于鉴定针对埃博拉病毒的体液免疫功能相关因素。
Immunity. 2021 Apr 13;54(4):815-828.e5. doi: 10.1016/j.immuni.2021.03.009.
6
Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.通过融合抑制作用,人源单克隆抗体对裂谷热病毒具有强大的中和作用。
Proc Natl Acad Sci U S A. 2021 Apr 6;118(14). doi: 10.1073/pnas.2025642118.
7
Crimean-Congo Hemorrhagic Fever Virus (CCHFV): A Silent but Widespread Threat.克里米亚-刚果出血热病毒(CCHFV):一种隐匿却广泛存在的威胁。
Curr Trop Med Rep. 2021;8(2):141-147. doi: 10.1007/s40475-021-00235-4. Epub 2021 Mar 16.
8
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的人类中和抗体需要完整的Fc效应子功能才能实现最佳治疗保护作用。
Cell. 2021 Apr 1;184(7):1804-1820.e16. doi: 10.1016/j.cell.2021.02.026. Epub 2021 Feb 12.
9
Coming together at the hinges: Therapeutic prospects of IgG3.铰链处相聚:IgG3 的治疗前景。
MAbs. 2021 Jan-Dec;13(1):1882028. doi: 10.1080/19420862.2021.1882028.
10
Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.流感血凝素特异性IgA的Fc效应功能仅限于茎部表位。
Proc Natl Acad Sci U S A. 2021 Feb 23;118(8). doi: 10.1073/pnas.2018102118.